Products
CE Global Private Equity offers a wide range of investment products and services for retail and corporate investors.
Welcome to the Investment Performance Case Study of UL Solutions Inc., which follows our clients' journeys of investing in UL Solutions Inc. between 12th Apr, 2024 and 12th Apr, 2024, during which the recorded share price produced a gain of 25%.
UL Solutions Inc. is a global leader in applied safety science, headquartered in Northbrook, Illinois. Founded in 1894 as Underwriters Laboratories, the company rebranded to UL Solutions in 2022 to reflect its expanded focus on safety, security, and sustainability. UL Solutions offers a comprehensive suite of services, including testing, inspection, and certification (TIC), as well as software and advisory solutions. These services support over 80,000 customers across more than 110 countries, helping them navigate complex regulatory landscapes, ensure product safety, and drive innovation. The company's offerings span various industries, such as automotive, healthcare, electronics, and energy. In 2023, UL Solutions reported revenues of $2.68 billion, demonstrating consistent growth and a strong market presence. Additionally, UL Solutions has been recognized as an innovator in environmental, social, and governance (ESG) services, reflecting its commitment to sustainability and responsible business practices. Listed on the New York Stock Exchange under the ticker symbol "ULS," UL Solutions continues to advance safety science, empowering businesses to innovate and grow safely and sustainably.

UL Solutions is a global safety science business providing testing, inspection, certification and related services to companies across numerous industries. Its operations support organisations seeking to demonstrate product safety, performance and compliance across increasingly complex international markets.
UL Solutions began trading on the New York Stock Exchange on 12 April 2024 following an initial public offering priced at $28.00 per share.
The case study records an outcome value of $34.94 during the company's market debut. Relative to the $28.00 entry price, this represents an increase of approximately 24.8%, reflecting a positive reception from public-market investors.


The case study of the Oxford Nanopore Technologies IPO in 2021

The case study of the Jin Medical International Ltd. IPO in 2024
